Approvals/TGA/PREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial

Approved

STANDARD

PREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial

Merck Sharp & Dohme (Australia) Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 905128198152ea8c
Product Name: PREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial
Artg Id: 289794
Artg Name: PREVYMIS letermovir 240 mg/12 mL concentrated injection for infusion vial
Sponsor: Merck Sharp & Dohme (Australia) Pty Ltd
Company Detail Path: /organization/merck-sharp-and-dohme-australia-pty-ltd
Artg Date: 2018-06-22
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-02678-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-02057-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

905128198152ea8c

Type

Standard